Ligand Pharma (LGND)
NASDAQ:LGND
Holding LGND?
Track your performance easily

Ligand Pharma (LGND) Financial Statements

795 Followers

Ligand Pharma Financial Overview

Ligand Pharma's market cap is currently ―. The company's EPS TTM is $2.311; its P/E ratio is 47.60; Ligand Pharma is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $1.35. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 41.53M$ 30.98M$ 28.10M$ 32.87M$ 26.37M
Gross Profit$ 38.63M$ 28.10M$ 26.46M$ 29.38M$ 24.70M
EBIT$ -65.39M$ 113.59M-$ -12.14M$ 3.46M
EBITDA$ -56.28M$ 122.35M--$ 12.20M
Net Income Common Stockholders$ -50.64M$ 86.14M$ 18.19M$ -10.27M$ 2.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 226.93M$ 310.59M$ 170.31M$ 190.50M$ 219.04M
Total Assets$ 866.40M$ 913.87M$ 787.22M$ 769.23M$ 758.11M
Total Debt$ 7.58M$ 6.19M$ 6.17M$ 6.33M$ 11.67M
Net Debt$ -219.35M$ -304.40M$ -164.14M$ -184.17M$ -207.37M
Total Liabilities$ 91.21M$ 107.35M$ 86.30M$ 101.33M$ 93.21M
Stockholders Equity$ 775.20M$ 806.52M$ 700.91M$ 667.90M$ 664.89M
Cash Flow-
Free Cash Flow$ 12.91M$ 18.63M--$ -285.00K
Operating Cash Flow$ 13.31M$ 18.73M$ 8.06M$ 7.65M$ -82.00K
Investing Cash Flow$ -54.76M$ -3.77M$ -10.28M$ -19.50M$ 7.56M
Financing Cash Flow$ 9.49M$ 12.18M$ 5.32M$ 3.27M$ -67.76M
Currency in USD

Ligand Pharma Earnings and Revenue History

Ligand Pharma Debt to Assets

Ligand Pharma Cash Flow

Ligand Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis